| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―18 |
Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2 |
Yuan Zhang, Matt D. Johansen, Scott Ledger, Rebecca Shipley, Guanshu Zhao, Ernest Moles, et al. (+6) Stuart Turville, Pall Thordarson, Philip M. Hansbro, Maria Kavallaris, Anthony D. Kelleher, Chantelle L. Ahlenstiel |
| 2 |
[GO] |
2025―Jan―20 |
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV |
Ellen Bowden-Reid, Ernest Moles, Anthony Kelleher, Chantelle Ahlenstiel |
| 3 |
[GO] |
2022―Nov―28 |
A comprehensive review on the COVID-19 vaccine and drug delivery applications of interpenetrating polymer networks |
Ebtisam A. Aldaais |
| 4 |
[GO] |
2022―Oct―19 |
Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19 |
Shohreh Alipour, Laleh Mahmoudi, Fatemeh Ahmadi |
| 5 |
[GO] |
2022―Apr―19 |
Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model |
Lok R. Pokhrel, Frank Williams, Paul P. Cook, Dorcas O’Rourke, Gina Murray, Shaw M. Akula |
| 6 |
[GO] |
2022―Mar―15 |
Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective |
Hagar I. Labouta, Robert Langer, Pieter R. Cullis, Olivia M. Merkel, Mark R. Prausnitz, Yasmine Gomaa, et al. (+2) Sara S. Nogueira, Tushar Kumeria |
| 7 |
[GO] |
2021―Sep―20 |
An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19 |
Ahmad Reza Farmani, Forough Mahdavinezhad, Carolina Scagnolari, Mahsa Kouhestani, Sadegh Mohammadi, Jafar Ai, et al. (+2) Mohammad Hasan Shoormeij, Nima Rezaei |
| 8 |
[GO] |
2021―Sep―03 |
Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations |
Mohammad Khedri, Reza Maleki, Mohammad Dahri, Mohammad Moein Sadeghi, Sima Rezvantalab, Hélder A. Santos, Mohammad-Ali Shahbazi |
| 9 |
[GO] |
2021―May―15 |
Mucosal and transdermal vaccine delivery strategies against COVID-19 |
Ashwini Kumar, Awanish Kumar |
| 10 |
[GO] |
2021―Mar―21 |
Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control |
Kai-Chieh Yang, Jung-Chen Lin, Hsiao-Han Tsai, Chung-Yao Hsu, Vicky Shih, Che-Ming Jack Hu |
| 11 |
[GO] |
2021―Jan―29 |
Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine |
Lara Milane, Mansoor Amiji |
